R.A. Escala Cornejo

Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis

Alejandro Olivares-Hernández, E. del Barco, Carmen Parra Pérez et al. · Biomedicines · 2022 · 30 citations · Full text

Renal Cell Carcinoma Associated With Xp11.2 Translocation/TFE3 Gene-fusion: A Long Response to mammalian target of rapamycin (mTOR) Inhibitors

Oliver R. Rua Fernández, R.A. Escala Cornejo, M Navarro et al. · Urology · 2018 · 21 citations

Long Response, Urology, Mammalian Target +9

Response to Treatment with an Anti-Interleukin-6 Receptor Antibody (Tocilizumab) in a Patient with Hemophagocytic Syndrome Secondary to Immune Checkpoint Inhibitors

Alejandro Olivares-Hernández, Luis Figuero-Pérez, María Antonieta Martin et al. · Case Reports in Oncological Medicine · 2021 · 20 citations · Full text

Large cell neuroendocrine carcinoma of the lung with atypical evolution and a remarkable response to lutetium Lu 177 dotatate

R.A. Escala Cornejo, P. García-Talavera, M Navarro et al. · Annals of Nuclear Medicine · 2018 · 12 citations

Tumor Biology, Malignant Disease, Oncogenic Agent +10

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab

Luis Figuero-Pérez, Alejandro Olivares-Hernández, R.A. Escala Cornejo et al. · Reumatología Clínica (English Edition) · 2020 · 12 citations · Full text

Sars-cov-2 Refractory, Immunology, Antiviral Therapy +6